We talk to MIT professor Daron Acemoglu about his book Power and Progress and unpack why making direct human-to-AI comparisons isn't necessarily helpful...
Target's (TGT) first quarter wasn't a direct strike on the bullseye, as shoppers continued to hesitate heading down the more discretionary departments of...
(Bloomberg) -- European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma is closely watching.Most...
By Tom Sims and Frank SiebeltFRANKFURT (Reuters) -Germany's Commerzbank said on Wednesday that its net profit nearly doubled in the first quarter, beating...
(Bloomberg) -- More than three years after China’s grand financial opening, it’s becoming clear to Wall Street giants that their dreams of windfall...
